Categories Earnings Calls, Technology

Snap Inc. (SNAP) Q3 2020 Earnings Conference Call

Listen to Snap Inc.  (NYSE: SNAP) Q3 2020 earnings call dated Oct. 20, 2020

Corporate Participants:

Betsy Miller Frank — Head of Investor Relations

Evan Spiegel — Chief Executive Officer

Jeremi Gorman — Chief Business Officer

Derek Andersen — Chief Financial Officer

Analysts:

Ross Sandler — Barclays — Analyst

Doug Anmuth — JPMorgan — Analyst

Michael Levine — Pivotal Research Group — Analyst

Heath Terry — Goldman Sachs — Analyst

Rich Greenfield — LightShed Partners — Analyst

Justin Post — Bank of America Merrill Lynch — Analyst

Eric Sheridan — UBS — Analyst

Brian Nowak — Morgan Stanley — Analyst

Mark Shmulik — Bernstein — Analyst

Read the full earnings transcript at https://news.alphastreet.com/snap-inc-snap-q3-2020-earnings-call-transcript/

Most Popular

Context Therapeutics: Another clinical-stage oncology research firm to go public soon

The US primary markets seem to be having a record-breaking start to the year, with over $171 billion raised in the first half of 2021 compared to $168 billion for

Biogen (BIIB) Stock: Does FDA nod for Aduhelm offer a buying opportunity?

The pharmaceutical industry has been witnessing hectic activity for some time, with most drug makers either channelizing their resources for vaccine development or engaging in COVID care programs. Biotechnology giant

IPO News: Monte Rosa Therapeutics will go public this week, here are a few things to know

Biotechnology company Monte Rosa Therapeutics is slated to go public this week. In a pandemic-ridden world, this industry is expanding at a healthy pace. The global biotechnology market is estimated

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top